Florean C, Lernoux M, Lorant A, Losson H, Bormans G, Schnekenburger M, Diederich M. HDAC6 inhibitors sensitize resistant t(11;14) multiple myeloma cells to a combination of bortezomib and BH3 mimetics. Haematologica; https://doi.org/10.3324/haematol.2024.286279 [Early view].